Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: September 18, 2007
Last updated: NA
Last verified: September 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2004
  Estimated Primary Completion Date: No date given